Faisal Ghiath Sukhtian

Insider Reports History

Location
Amman, Jordan
Signature
/s/Lawrence A. Kenyon, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Faisal Ghiath Sukhtian:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Outlook Therapeutics, Inc. Director Stock Option (Right to Buy) 117K Oct 3, 2025 Direct

Insider Reports Filed by Faisal Ghiath Sukhtian

Symbol Company Period Transactions Value $ Form Type Date Filed Role
OTLK Outlook Therapeutics, Inc. Oct 1, 2025 2 $0 4 Oct 3, 2025 Director
OTLK Outlook Therapeutics, Inc. Feb 4, 2025 1 $0 4 Feb 6, 2025 Director
OTLK Outlook Therapeutics, Inc. Oct 1, 2024 3 $0 4 Oct 3, 2024 Director
OTLK Outlook Therapeutics, Inc. Mar 7, 2024 1 $0 4 Mar 8, 2024 Director
OTLK Outlook Therapeutics, Inc. Oct 4, 2023 1 $0 4 Oct 5, 2023 Director
OTLK Outlook Therapeutics, Inc. Mar 29, 2023 1 $0 4 Mar 31, 2023 Director
OTLK Outlook Therapeutics, Inc. Oct 7, 2022 1 $38.7K 4 Oct 11, 2022 Director
OTLK Outlook Therapeutics, Inc. Oct 5, 2022 1 $0 4 Oct 7, 2022 Director
OTLK Outlook Therapeutics, Inc. Apr 21, 2022 1 $0 4 Apr 22, 2022 Director, 10%+ Owner
OTLK Outlook Therapeutics, Inc. Mar 23, 2022 1 $0 4 Mar 24, 2022 Director
OTLK Outlook Therapeutics, Inc. Dec 2, 2021 1 $25.2K 4 Dec 2, 2021 Director
OTLK Outlook Therapeutics, Inc. Oct 5, 2021 1 $0 4 Oct 7, 2021 Director